TScan Therapeutics, Inc.
TCRX
$1.44
$0.1410.77%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 51.06% | 25.85% | 42.54% | 70.26% | 60.00% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 19.11% | 38.29% | 27.86% | -63.43% | -46.51% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 50.70% | 25.98% | 23.66% | 63.24% | 56.48% |
|
|
|||||
| Total Current Assets | 50.70% | 25.98% | 23.66% | 63.24% | 56.48% |
| Net Property, Plant & Equipment | 0.51% | -0.04% | 0.79% | 3.74% | 2.94% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.78% | 2.40% | 1.48% | 16.40% | 15.90% |
| Total Assets | 36.37% | 19.44% | 18.28% | 38.75% | 36.70% |
|
|
|||||
| Total Accounts Payable | 80.20% | 14.11% | -8.37% | -23.44% | -18.48% |
| Total Accrued Expenses | 49.00% | 23.83% | 34.07% | 21.80% | 60.62% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -30.68% | -28.95% | 231.43% | 164.21% | 79.11% |
| Total Finance Division Other Current Liabilities | 11.48% | -34.90% | -44.24% | 2,357.70% | 145.34% |
| Total Other Current Liabilities | 11.48% | -34.90% | -44.24% | 2,357.70% | 145.34% |
| Total Current Liabilities | 20.58% | -13.55% | 9.84% | 124.10% | 72.32% |
|
|
|||||
| Total Current Liabilities | 20.58% | -13.55% | 9.84% | 124.10% | 72.32% |
| Long-Term Debt | 20.12% | 6.28% | -32.33% | -20.52% | -8.84% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.70% | 5.98% | 5.95% | 11.94% | 11.56% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -75.44% | -50.81% | -48.42% | 13,116.67% | 11,373.47% |
| Total Liabilities | 7.31% | -2.84% | -5.28% | 23.34% | 21.70% |
|
|
|||||
| Common Stock & APIC | 54.60% | 43.19% | 42.73% | 54.74% | 54.56% |
| Retained Earnings | -51.49% | -48.82% | -50.94% | -53.50% | -56.33% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 59.72% | 35.59% | 33.90% | 57.61% | 51.73% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 59.72% | 35.59% | 33.90% | 57.61% | 51.73% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 59.72% | 35.59% | 33.90% | 57.61% | 51.73% |
|
|
|||||